Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Ware

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
The Journal of Pediatrics|November 3, 2009
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trialRussell E Ware, Renee C Rees, Sharada A Sarnaik, et al.
The Journal of Infectious Diseases|August 29, 2024
Circulating immune complexes and G6PD deficiency predict readmissions for blackwater fever and severe anemia in children with severe malaria in Eastern UgandaRuth Namazzi, Kagan A Mellencamp, Robert O Opoka, et al.
Nature Genetics|July 16, 2002
Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly)Katrin Hoffmann, Christine K Dreger, Ada L Olins, et al.
American Journal of Hematology|January 11, 2018
Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan AfricaPatrick T McGann, Thomas N Williams, Peter Olupot-Olupot, et al.
British Journal of Haematology|October 15, 2024
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan AfricaCatherine I Segbefia, Luke R Smart, Susan E Stuber, et al.
Acta Haematologica|August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan AfricaLuke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.
Journal of Community Genetics|May 17, 2020
Empowering newborn screening programs in African countries through establishment of an international collaborative effortBradford L Therrell, Michele A Lloyd-Puryear, Kwaku Ohene-Frempong, et al.
Blood Advances|November 15, 2018
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian childrenPatrick T McGann, Anne M Williams, Graham Ellis, et al.
British Journal of Haematology|January 5, 2023
Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel lociEric Jay Earley, Shannon Kelly, Fang Fang, et al.
American Journal of Hematology|September 29, 2015
Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trialJane S Hankins, Mary Beth McCarville, Angela Rankine-Mullings, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
The Journal of Pediatrics|November 3, 2009
Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trialRussell E Ware, Renee C Rees, Sharada A Sarnaik, et al.
The Journal of Infectious Diseases|August 29, 2024
Circulating immune complexes and G6PD deficiency predict readmissions for blackwater fever and severe anemia in children with severe malaria in Eastern UgandaRuth Namazzi, Kagan A Mellencamp, Robert O Opoka, et al.
Nature Genetics|July 16, 2002
Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly)Katrin Hoffmann, Christine K Dreger, Ada L Olins, et al.
American Journal of Hematology|January 11, 2018
Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan AfricaPatrick T McGann, Thomas N Williams, Peter Olupot-Olupot, et al.
British Journal of Haematology|October 15, 2024
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan AfricaCatherine I Segbefia, Luke R Smart, Susan E Stuber, et al.
Acta Haematologica|August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan AfricaLuke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.
Journal of Community Genetics|May 17, 2020
Empowering newborn screening programs in African countries through establishment of an international collaborative effortBradford L Therrell, Michele A Lloyd-Puryear, Kwaku Ohene-Frempong, et al.
Blood Advances|November 15, 2018
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian childrenPatrick T McGann, Anne M Williams, Graham Ellis, et al.
British Journal of Haematology|January 5, 2023
Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel lociEric Jay Earley, Shannon Kelly, Fang Fang, et al.
American Journal of Hematology|September 29, 2015
Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trialJane S Hankins, Mary Beth McCarville, Angela Rankine-Mullings, et al.
Pageof 27